Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Kendall Moisture Barrier Cream** is a topical over-the-counter skin protectant formulated primarily with dimethicone, designed to form a protective barrier on intact or irritated skin. It prevents and temporarily relieves minor skin irritation and itching due to rashes, chafing, chapped or cracked skin, diaper rash, and moisture-related damage from incontinence or body fluids. The cream works by creating a breathable, water-repellent layer that locks in moisture and shields against irritants without clogging pores, making it suitable for sensitive, fragile, dry, or periwound skin. Apply thinly to clean, dry skin as needed, typically reapplying daily or more frequently on washed areas; it is non-greasy, hypoallergenic, and well-tolerated but should not be used on deep wounds, punctures, animal bites, or serious burns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kendall Moisture Barrier Cream.